Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial
Hospices Civils de Lyon · Centre National de la Recherche Scientifique · +33 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,061
total citations
- FWCI
- 48.19
- Percentile
- 100%
- References
- 35
Citations per year
Authors
30- GSGilles SallesCorresponding
Hospices Civils de Lyon, Centre National de la Recherche Scientifique, Université Claude Bernard Lyon 1
- JFJohn F. Seymour
Peter MacCallum Cancer Centre, The University of Melbourne
- FOFritz Offner
Ghent University Hospital, Ghent University
- ALArmando López‐Guillermo
Hospital Clínic de Barcelona
- DBDavid Belada
Charles University, University Hospital Hradec Králové
Topics & keywords
Topics
Keywords
- Rituximab
- Follicular lymphoma
- Medicine
- Internal medicine
- Chemotherapy
- Oncology
- Lymphoma
- Maintenance therapy
No related works found for this paper.